Evaluating Different Methods of Circulating Tumor DNA Quantification in Oncology Patients
T
Tim Lautenschlaeger, MD
Primary Investigator
Enrolling By Invitation
18-100 years
All
Phase
N/A
400 participants needed
5 Locations
Brief description of study
What is the purpose of this study?
This study aims to invent a test that can see tiny pieces from people with cancer (specifically DNA from a person’s cancer) in blood and urine better than tests that can currently be done. In the future, this test can possibly be used to find a small cancer before other tests can find it.
THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic.
Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office
Email: iutrials@iu.edu
Phone: (317) 278-5632
Detailed description of study
What will happen during the study?
- Participants will be asked to complete a 24 hour urine collection. Participants may be asked to complete a blood draw and some swab samples. Samples will be collected throughout the participant's cancer treatment journey. Researchers will ask permission to access participants' medical records for up to 10 years.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Healthy, Cancer, Hepatitis C
-
Age: Between 18 Years - 100 Years
-
Gender: All
Inclusion Criteria:
- Healthy individuals, patients with cancer, and patients with Hepatitis C
- Cancer patients who plan to undergo therapy
- Patients with Hepatitis C with a recent positive test
- Ability to provide written informed consent and HIPAA authorization
Exclusion Criteria:
- Dialysis dependent
Updated on
01 Aug 2024.
Study ID: 11731, CTO-IUSCCC-0769
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
